Hospitals, physicians and other providers are increasingly looking for opportunities to consolidate as the health care marketplace continues to evolve. Issues like compatibility, synergies, and financial considerations typically drive planning and preliminary discussions, but Wally Van Valkenburg and Barbara Nay of Stoel Rives LLP say that evaluating and managing antitrust risk should also be high on the list of issues for discussion. Failure to consider antitrust risk early on can easily result in a significant investment of time and resources in a deal that can’t be completed, they say. Van Valkenburg and Nay offer a checklist for health care executives who are considering a merger.
Click here to download this article (PDF).